March 4th 2024
A new study points to disparities for patients in respiratory failure, which can have dire consequences. The lead researchers talk about the implications.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
The Effects of Classroom Air Purifiers, Pest Management on Students with Active Asthma
September 24th 2021In a study conducted by JAMA, results were recently released sharing children with active asthma had reduced symptom days, but not significantly, in the use of a school-wide integrated pest management program or a high-efficiency particulate air filter purifier in recorded 2-week time periods.
Read More
Renovion, COPD Foundation Launch Partnership to Address Unmet Needs for COPD Patients
September 23rd 2021Efforts are underway to accelerate the development of a novel therapy for excessive airway mucus and inflammation treatment for patients with chronic obstructive pulmonary disease and non-cystic fibrosis bronchiectasis.
Read More
5 Takeaways About Pulmonary Rehabilitation
September 23rd 2021Three experts say that pulmonary rehabilitation programs don’t necessarily result in improved lung function but are associated with improved physical and other sorts of functioning. Less than 5% of those who might benefit from pulmonary rehabilitation services received them.
Read More
ICER Foresees AstraZeneca’s Tezepelumab for Severe Asthma As Being Only Modestly Cost Effective
September 17th 2021Tezepelumab, which is being currently reviewed by the FDA, provides small improvements in daily symptoms and quality of life but is only modestly cost-effectiveness at the anticipated price, according to the cost-effectiveness group's calculations.
Read More
FDA Roundup: Pediatric Indications, More in Alzheimer's Pipeline?
June 26th 2021Regulatory actions for drugs for children, a combination cancer therapy, launches of two generic therapies for COPD, and cancer and Alzheimer’s therapies receive Breakthrough Designation round out this week’s FDA news.
Read More